RNA DELIVERY SYSTEM FOR TREATMENT OF HUNTINGTON'S DISEASE

An RNA delivery system for the treatment of Huntington's disease. The system comprises a viral vector, the viral vector carries RNA fragments capable of treating Huntington's disease, the viral vector is capable of enrichment in organ tissues of a host and endogenously and spontaneously forming a complex containing the RNA fragments capable of treating Huntington's disease in the organ tissues of the host, and the complex can deliver the RNA fragments into a target tissue to treat Huntington's disease. The safety and reliability of the RNA delivery system for the treatment of Huntington's disease have been fully verified. The system has good medicinal properties, strong versatility, and has economic benefits and application prospects..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 07. Feb. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

ZHANG CHENYU [VerfasserIn]
CHEN XI [VerfasserIn]
FU ZHENG [VerfasserIn]
LI JING [VerfasserIn]
ZHANG XIANG [VerfasserIn]
ZHOU XINYAN [VerfasserIn]
ZHANG LI [VerfasserIn]
YU MENGCHAO [VerfasserIn]
GUO HONGYUAN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
bio
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-02-07, Last update posted on www.tib.eu: 2024-03-26, Last updated: 2024-03-29

Patentnummer:

EP4317434

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA00020904X